MC-Gly-Gly-Phe combines a modular linking group with a flexible diglycine and an aromatic phenylalanine that shapes hydrophobic behavior. The construct supports investigations of cleavage sensitivity and enzymatic selectivity. Researchers evaluate its folding tendencies and solvent interactions. Use includes prodrug-model development, peptide synthesis studies, and mechanistic profiling.
CAT No: R2639
CAS No:1599440-15-9
Synonyms/Alias:MC-Gly-Gly-Phe;1599440-15-9;(2S)-2-[[2-[[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]acetyl]amino]acetyl]amino]-3-phenylpropanoic acid;MFCD32690114;SCHEMBL17003656;WLZ3750;DTXSID901130594;(2S)-2-(2-{2-[6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamido]acetamido}acetamido)-3-phenylpropanoic acid;EX-A5701;AKOS040743568;AC-32500;DA-65291;HY-44235;MS-28742;PD125818;CS-0106193;E79158;(6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl)glycylglycyl-L-phenylalanine;N-[6-(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]glycylglycyl-L-phenylalanine;(S)-2-(2-(2-(6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamido)acetamido)acetamido)-3-phenylpropanoic acid;
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.